Close Menu

NEW YORK – OraSure Technologies announced on Wednesday the pricing of 8 million shares of its common stock at $11 per share.

Net proceeds from the offering are estimated at approximately $82.5 million, the Bethlehem, Pennsylvania-based company said.

OraSure has also granted the underwriters a 30-day option to purchase up to an additional 1.2 million shares of its common stock.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Reuters reports that Germany is seeking to sequence 5 percent of patient samples that test positive for SARS-CoV-2.

23andMe and Medscape say primary care physicians are increasingly more comfortable with discussing direct-to-consumer genetic testing results.

The publisher of the Science family of journals will allow some authors to place peer-reviewed versions of their papers into publicly accessible repositories.

In Science this week: analysis of genome-wide association studies of chronic kidney disease, and more.